Here, we demonstrated the important role of TGase2 in hyperglycemia-induced microvascular leakage in the glomerulus, and thus TGase2 inhibitors can be considered as potential therapeutics, although further studies on their pharmacokinetics and efficacy are required. This evidence concerns the gene TGM2 and Hyperglycemia.